Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Development and validation of a risk prediction...
Conference

Development and validation of a risk prediction model for poor performance status and severe symptoms among cancer patients.

Abstract

12097 Background: Existing cancer predictive tools focus on survival, but few incorporate patient-reported outcomes to predict quality-of-life domains, such as symptoms and performance status. The objective was to develop and validate a predictive cancer model (called PROVIEW) for poor performance status and severe symptoms over time. Methods: We used a retrospective, population-based, cohort study of patients, with a cancer …

Authors

Seow H; Tanuseputro P; Barbera LC; Earle C; Guthrie D; Isenberg S; Juergens RA; Brouwers MC; Myers J; Sutradhar R

Volume

38

Pagination

pp. 12097-12097

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

May 20, 2020

DOI

10.1200/jco.2020.38.15_suppl.12097

Conference proceedings

Journal of Clinical Oncology

Issue

15_suppl

ISSN

0732-183X